Editorial comment: Vernakalant: Additional evidence for safety and efficacy for new onset atrial fibrillation

Journal of the American College of Cardiology

Volumn 57, Issue 3, 2011, Pages 322-323

  Lindsay, Bruce D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

amiodarone; antiarrhythmics; atrial fibrillation; cardioversion; vernakalant

Indexed keywords

AMIODARONE; IBUTILIDE; PLACEBO; VERNAKALANT; ANISOLE DERIVATIVE; PYRROLIDINE DERIVATIVE;

CARDIOVERSION; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE ARRHYTHMIA; HUMAN; PRIORITY JOURNAL; TELEMETRY; TORSADE DES POINTES; ACUTE DISEASE; EVIDENCE BASED MEDICINE; METHODOLOGY; NOTE; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ACUTE DISEASE; ANISOLES; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; EVIDENCE-BASED MEDICINE; HUMANS; PYRROLIDINES; TREATMENT OUTCOME;

EID: 78651314565     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.08.633     Document Type: Editorial

References (10)

1. A.S. Go, E.M. Hylek, K.A. Phillips, Y.C. Chang, and L.E. Henault Prevalence of diagnosed atrial fibrillation in adults National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2730 2735
2. L.Y. Chen, and W.K. Shen Epidemiology of atrial fibrillation: a current perspective Heart Rhythm 4 2007 S1 S6
3. I. Salveliaeva, and A.J. Camm Clinical trends in atrial fibrillation at the turn of the millennium J Intern Med 250 2001 369 372
4. K.S. Coyne, C. Paramore, S. Grandy, M. Mercader, M. Reynolds, and P. Zimetbaum Assessing the direct costs of treating nonvalvlular atrial fibrillation in the United States Value Health 9 2006 348 356
5. D. Fedida, P.M. Orth, and J. Chen The mechanism of atrial antiarrhythmic action of RSD1235 J Cardiovasc Electrophysiol 16 2005 1227 1238
6. A.J. Camm, A. Capucci, S.H. Hohnloser AVRO Investigators A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation J Am Coll Cardiol 57 2011 313 321
7. D. Roy, C.M. Pratt, and C. Torp-Pederson Vernakalant hydrochloride for rapid conversion of atrial fibrillation A phase 3, randomized, placebo-controlled trial Circulation 117 2008 1518 1525
8. P.R. Kowey, P. Doria, and L.B. Mitchel Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo controlled trial Circ Arrhythm Electrophysiol 2 2009 652 659
9. K.A. Ellenbogen, B.S. Stambler, and M.A. Wood Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study J Am Coll Cardiol 28 1996 130 136
10. B.S. Stambler, M.A. Wood, K.A. Ellenbogen, K.T. Perry, B.S. Wakefield, J.T. Vanderlugt Ibutilide Repeat Dose Study Investigators Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation Circulation 94 1996 1613 1621